Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neuron

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuron.2016.07.007PMID 27477021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

  2016cited by this paper

• Therapeutic potential of SSZ in modulating Alzheimer’s disease pathology: A multi-targeted experimental approach

  2026cites this paper
• Serum Galectin-3 as a biomarker in acute inflammatory polyradiculoneuropathies: a cohort study

  2026cites this paper
• Serum levels of neurofilament light chain (NfL) and glial fibrillary acid protein (GFAP) in patients with asymptomatic and symptomatic carotid artery stenosis.

  2026cites this paper
• Current potential biomarkers for Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis: review of literature

  2026influential citation
• Neurofilament light chain protein exposure contributes to protein aggregation, microgliosis, astrogliosis and neuroinflammation via p38/MK2/NF-κB/CREB1/Nrf2/HO-1 signalling leading to Parkinson's disease.

  2026cites this paper
• Amyloid Beta Oligomers as Early Triggers of Neuronal Cytoskeleton Dysfunction in Alzheimer's Disease.

  2026cites this paper
• Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis

  2025cites this paper
• From Cell Architecture to Mitochondrial Signaling: Role of Intermediate Filaments in Health, Aging, and Disease

  2025cites this paper
• Blood-based biomarkers in mild behavioral impairment: an updated overview

  2025cites this paper
• Increased Serum Neurofilament Light Chain Concentration Associated With Microglial Morphology Changes in Chronically‐Starved Mice

  2025cites this paper
• Chronic effects of traumatic brain injury and the impact of biperiden treatment in a male rat model.

  2025cites this paper
• Correlation between serum neurofilament light chain and short-term outcomes in patients with hypertensive intracerebral hemorrhage

  2025cites this paper
• APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology

  2025cites this paper
• Blood biomarkers for clinical applications in Alzheimer's disease: A narrative review

  2025cites this paper
• Acute plasma VEGF-A levels are associated with raised intracranial pressure and chronic lesion volume after Traumatic Brain Injury

  2025cites this paper
• Neurofilament Biomarkers in Neurology: From Neuroinflammation to Neurodegeneration, Bridging Established and Novel Analytical Advances with Clinical Practice

  2025cites this paper
• Nighttime dexmedetomidine modifies the association between neurofilament light chain and delirium severity after major cardiac surgery: a secondary analysis of the MINDDS trial.

  2025cites this paper
• Association of Ambient Particulate Matter and Nitrogen Dioxide with Hospital Admissions for Parkinson's Disease: A Nationwide Case-Crossover Study in China.

  2025cites this paper
• Association Between Serum Methylmalonic Acid (A Marker of Mitochondrial Dysfunction) and Serum Neurofilament Light Chains in a U.S. Population: a Cross‐Sectional Analysis From NHANES 2013–2014

  2025cites this paper
• Circulating Biomarkers of Neurodegeneration and Risk of Cognitive Impairment.

  2025cites this paper
• Cerebrospinal fluid and blood neurofilament light chain in Parkinson's disease and atypical parkinsonian syndromes: a systematic review and Bayesian network meta-analysis

  2025cites this paper
• Proteolysis‐Based Biomarker Repertoire of the Neurofilament Proteome

  2025cites this paper
• Microglial replacement in a Sandhoff disease mouse model reveals myeloid-derived β-hexosaminidase is necessary for neuronal health

  2025cites this paper
• Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice

  2025cites this paper
• Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation.

  2025cites this paper
• Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives

  2025cites this paper
• Linking evidence for targeted blood biomarkers in post-stroke cognitive impairment and dementia

  2025cites this paper
• Fluid-based biomarkers for neurodegenerative diseases.

  2025cites this paper
• Neurofilament light chain in Alzheimer's disease.

  2025cites this paper
• Biomarkers in ALS trials: from discovery to clinical utility

  2025cites this paper
• Plasma neurofilament light chain as a predictor of multiple system atrophy in idiopathic REM sleep behavior disorder

  2025cites this paper
• An Improved Method for Sampling and Quantitative Protein Analytics of Cerebrospinal Fluid of Individual Mice

  2025cites this paper
• Multi-Tissue Profiling Reveals tissue-specific protein regulation and relationships Between Protein Quantitative Trait Loci (pQTLs) and Cardiometabolic Disease

  2025cites this paper
• Comparison of Simoa and Lumipulse Neurofilament Light Chain Measurements in Alzheimer’s Cerebrospinal Fluid: Preliminary Findings

  2025cites this paper
• Linking Cell Architecture to Mitochondrial Signaling in Neurodegeneration: The Role of Intermediate Filaments

  2025cites this paper
• Associations Between Nicotine Metabolites and Serum Neurofilament Light Chain Levels in the General Population

  2025cites this paper
• Natural History and Clinical Associations of Plasma Vascular Endothelial Growth Factor A

  2025cites this paper
• Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chain

  2025cites this paper
• Systemic Disease Progression and Neurodegeneration in the Gbe1ys/ys Mouse Model of Glycogen Storage Disease IV.

  2025cites this paper
• Crumbling Pathogenesis and Biomarkers for Diabetic Peripheral Neuropathy

  2025cites this paper
• Enhanced legumain activity links progranulin deficiency to TDP-43 pathology in frontotemporal lobar degeneration

  2024cites this paper
• Microfluidic Systems: Recent Advances in Chronic Disease Diagnosis and Their Therapeutic Management

  2024cites this paper
• Genetic diversity promotes resilience in a mouse model of Alzheimer's disease

  2024cites this paper
• Molecular Mechanisms of Neurofilament Alterations and its Application in Assessing Neurodegenerative Disorders.

  2024influential citation
• Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer’s Disease and Multiple Sclerosis

  2024cites this paper
• Correlation between neurofilament, HMGB1, MMP9, ds DNA blood levels and cognitive impairment in patients with neuropsychiatric systemic lupus erythematosus

  2024cites this paper
• Neuroinflammation, neurodegeneration and alteration of spatial memory in BALB/c mice through ampicillin-induced gut dysbiosis; NOS2 and NFL involvement in a microbiota-gut-brain axis model.

  2024cites this paper
• Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy

  2024cites this paper
• An improved method for sampling and quantitative protein analytics of cerebrospinal fluid of single mice

  2024cites this paper
• Pumping up the Fight against Multiple Sclerosis: The Effects of High-Intensity Resistance Training on Functional Capacity, Muscle Mass, and Axonal Damage

  2024cites this paper
• Association between sleep duration and serum neurofilament light chain levels among adults in the United States

  2024influential citation
• Predictive value of serum neurofilament light chain for cognitive impairment in Parkinson’s disease

  2024cites this paper
• Exploiting blood-based biomarkers to align preclinical models with human traumatic brain injury

  2024cites this paper
• The impact of COVID-19 on accelerating of immunosenescence and brain aging

  2024cites this paper
• The spectrum of behavioral disorders in amyotrophic lateral sclerosis: current view

  2024cites this paper
• Biofluid Markers and Tissue Biopsies Analyses for the Prodromal and Earliest Phase of Parkinson’s Disease

  2024cites this paper
• Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

  2024cites this paper
• GBA1 inactivation in oligodendrocytes affects myelination and induces neurodegenerative hallmarks and lipid dyshomeostasis in mice

  2024cites this paper
• Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study

  2024cites this paper
• Emerging Trends: Neurofilament Biomarkers in Precision Neurology

  2024cites this paper
• BIN1K358R suppresses glial response to plaques in mouse model of Alzheimer's disease

  2024cites this paper
• Combination of serum markers with optical coherence tomography angiography for evaluating neuromyelitis optica spectrum disorders and multiple sclerosis.

  2024cites this paper
• Alternating hemiplegia of childhood associated mutations in Atp1a3 reveal diverse neurological alterations in mice

  2024cites this paper
• Digging into the intrinsic capacity concept: can it be applied to Alzheimer's disease?

  2024cites this paper
• A framework for translating tauopathy therapeutics: Drug discovery to clinical trials

  2024cites this paper
• Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease

  2024cites this paper
• Identification of RN7SK LncRNA as a novel biomarker in Alzheimer’s disease using bioinformatics and expression analysis

  2024cites this paper
• A Critical Appraisal of Blood-Based Biomarkers for Alzheimer's Disease.

  2024cites this paper
• Characterization of pSer129-αSyn Pathology and Neurofilament Light-Chain Release across In Vivo, Ex Vivo, and In Vitro Models of Pre-Formed-Fibril-Induced αSyn Aggregation

  2024cites this paper
• NLRP3 inflammasome activation and pyroptosis are dispensable for tau pathology

  2024cites this paper
• Navigating the Landscape of Plasma Biomarkers in Alzheimer's Disease: Focus on Past, Present, and Future Clinical Applications

  2024cites this paper
• Effects of Galactooligosaccharides on the Gut Microbiome in Patients with Alzheimer's Dementia

  2024cites this paper
• Inflammatory Markers Predict Blood Neurofilament Light Chain Levels in Acute COVID-19 Patients

  2024cites this paper
• Association between cadmium exposure and serum neurofilament light chain levels: A nationwide population-based survey.

  2024cites this paper
• J-shaped relationship of serum neurofilament light chain with urinary albumin excretion in US adults: NHANES 2013–2014

  2024cites this paper
• Blood biomarker profiles in young-onset neurocognitive disorders: A cohort study

  2024cites this paper
• Biomarkers in Alzheimer's disease.

  2024cites this paper
• Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature

  2024cites this paper
• Dietary vitamin K intake is associated with decreased neurofilament light chain among middle-aged and older adults from the NHANES

  2024cites this paper
• Alpha‐synuclein pathology in isolated rapid eye movement sleep behaviour disorder: a meta‐analysis

  2024cites this paper
• Motor deficits and brain pathology in the Parkinson’s disease mouse model hA53Ttg

  2024cites this paper
• Long COVID as a Disease of Accelerated Biological Aging: An Opportunity to Translate Geroscience Interventions.

  2024cites this paper
• Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges

  2023cites this paper
• Serum neurofilament light chain levels are associated with all-cause mortality in the general US population

  2023cites this paper
• Hypothalamic protein profiling from mice subjected to social defeat stress

  2023cites this paper
• Blood neurofilament light chain in Parkinson’s disease

  2023cites this paper
• A mouse mutant deficient in both neuronal ceroid lipofuscinosis‐associated proteins CLN3 and TPP1

  2023cites this paper
• Uncovering a neurological protein signature for severe COVID-19

  2023cites this paper
• Postural control of Parkinson’s disease: A visualized analysis based on Citespace knowledge graph

  2023cites this paper
• Extracellular Matrix Changes in Subcellular Brain Fractions and Cerebrospinal Fluid of Alzheimer’s Disease Patients

  2023cites this paper
• Structural brain network deviations predict recovery after traumatic brain injury.

  2023cites this paper
• Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis

  2023cites this paper
• Plasma neurofilament light levels show elevation prior to diagnosis of sporadic motor neuron disease in the UK Biobank cohort

  2023cites this paper
• Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting

  2023cites this paper
• Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder

  2023cites this paper
• CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tauopathy mouse model

  2023cites this paper
• Review of Neurofilaments as Biomarkers in Sepsis-Associated Encephalopathy

  2023cites this paper
• Neural cortical organoids from self-assembling human iPSC as a model to investigate neurotoxicity in brain ischemia

  2023cites this paper
• Investigating the characteristics and correlates of systemic inflammation after traumatic brain injury: the TBI-BraINFLAMM study

  2023cites this paper
• An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants

  2023cites this paper